AAAAAA
Results:
1-8
|
Results: 8
Authors:
Brugnatelli, S
Riccardi, A
Danova, M
Pugliese, P
Tinelli, C
Luchena, G
Bernardo, A
Giardina, G
Fava, S
Montanari, G
Pedrotti, C
Poli, AM
Citation: S. Brugnatelli et al., Sequential docetaxel and vinorelbine for patients with advanced breast cancer previously treated with anthracyclines: A phase II study, ONCOL REP, 8(4), 2001, pp. 801-805
Authors:
Riccardi, A
Pugliese, P
Danova, M
Brugnatelli, S
Grasso, D
Giordano, M
Bernardo, G
Giardina, G
Fava, S
Montanari, G
Pedrotti, C
Trotti, G
Rinaldi, E
Poli, M
Tinelli, C
Citation: A. Riccardi et al., A phase II study of sequential 5-fluorouracil, epirubicin and cyclophosphamide (FEC) and paclitaxel in advanced breast cancer (Protocol PVBC 97/01), BR J CANC, 85(2), 2001, pp. 141-146
Authors:
Danova, M
Porta, C
Ferrari, S
Brugnatelli, S
Comolli, G
Riccardi, A
Ascari, E
Citation: M. Danova et al., Cell cycle status and apoptosis of hematopoietic progenitor cells releasedinto the peripheral blood after taxanes and granulocyte colony-stimulatingfactor in breast cancer patients, ONCOL REP, 7(3), 2000, pp. 585-589
Authors:
Riccardi, A
Tinelli, C
Brugnatelli, S
Pugliese, P
Giardina, V
Giordano, M
Danova, M
Richetti, A
Fava, S
Rinaldi, E
Fregoni, V
Trotti, G
Poli, A
Citation: A. Riccardi et al., Doubling of the epirubicin dosage within the 5-fluorouracil, epirubicin and cyclophosphamide regimen: a prospective, randomized, multicentric study on antitumor effect and quality of life in advanced breast cancer, INT J ONCOL, 16(4), 2000, pp. 769-776
Authors:
Pugliese, P
Danova, M
Brugnatelli, S
Piccolo, G
Riccardi, A
Ascari, E
Citation: P. Pugliese et al., Acute rhabdomyolysis after high-dose chemotherapy and circulating progenitor cell autografting for breast cancer, HAEMATOLOG, 85(6), 2000, pp. 672-672
Authors:
Riccardi, A
Mora, O
Tinelli, C
Valentini, D
Brugnatelli, S
Spanedda, R
De Paoli, A
Barbarano, L
Di Stasi, M
Giordano, M
Delfini, C
Nicoletti, G
Bergonzi, C
Rinaldi, E
Piccinini, L
Ascari, E
Citation: A. Riccardi et al., Long-term survival of stage I multiple myeloma given chemotherapy just after diagnosis or at progression of the disease: a multicentre randomized study, BR J CANC, 82(7), 2000, pp. 1254-1260
Authors:
Ferrari, S
Danova, M
Porta, C
Comolli, G
Brugnatelli, S
Pugliese, P
Riccardi, A
Ascari, E
Citation: S. Ferrari et al., Circulating progenitor cell release and functional characterization after Topotecan plus G-CSF and erythropoietin in small cell lung cancer patients, INT J ONCOL, 15(4), 1999, pp. 811-815
Authors:
Riccardi, A
Brugnatelli, S
Giordano, M
Danova, M
Pugliese, P
Tinelli, C
Klersy, C
Richetti, A
Fava, S
Nastasi, G
Rinaldi, E
Fregoni, V
De Monte, A
Trotti, G
Bovio, A
Ascari, E
Citation: A. Riccardi et al., Myeloprotective effect of early primary granulocyte-colony stimulating factor during six courses of intensified 5-fluorouracil, epirubicin and cyclophosphamide (120FEC) chemotherapy for advanced breast cancer, TUMORI, 84(5), 1998, pp. 540-546
Risultati:
1-8
|